PKI News and Press, PerkinElmer Inc. From 02/24/23

Company will showcase ultrasensitive platform for high-throughput screening applications at SLAS2023 alongside its newest NGS liquid handler while highlighting other workflow innovations PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier worl...

PerkinElmer, Inc. (PKI) Q4 2022 Earnings Conference Call February 14, 2023, 08:00 AM ET Company Participants Steve Willoughby - SVP, IR Prahlad Singh - President and CEO Max Krakowiak - SVP and CFO Conference Call Participants Derik de Bruin - Bank of Ameri...

PerkinElmer press release ( NYSE: PKI ): Q4 Non-GAAP EPS of $1.70 beats by $0.04 . Revenue of $1.09B (-19.9% Y/Y) beats by $20M . Initiates Full Year 2023 Guidance: For the full year 2023, the Company forecasts total revenue from continuing operations of $2.94 bil...

Fourth quarter revenue from continuing operations of $741 million; (28)% reported growth; (23)% organic growth; 8% non-COVID organic growth Combined* total fourth quarter revenue of $1,089 million; 8% combined non-COVID organic growth Fourth quarter GAAP EPS from continuing operat...

Summary S&P 500 blended EPS growth for Q4 increases for the first time in 3 weeks, now expected to come in at -4.9%. Peak earnings season rolls on this week with 1,276 global companies expected to report, as investors start to focus on Consumer Discretionary names. Potential sur...

PerkinElmer ( NYSE: PKI ) is scheduled to announce Q4 earnings results on Tuesday, February 14th, before market open. The consensus EPS Estimate is $1.66 (-35.2% Y/Y) and the consensus Revenue Estimate is $1.07B (-21.3% Y/Y). Over the last 2 years, PKI has beaten EPS estimat...

Summary Waters Corporation has been a source of relative stability over the past several months, with the company performing slightly better than the broader market. This comes as sales rise but also while profits and cash flows come under some pressure. If shares were cheaper, the ...

Summary InMode Ltd. has 80%+ gross margins and 40%+ operating margins within a growing industry. The market is overestimating short-term worries that likely won't have a material effect on long-term cash flows. On both a relative basis and through a discounted cash flow, I estimate ...

Summary PerkinElmer continues to offer long-term upside potential with its management of capital and acquisitions. The economic value of its transactions has created a healthy return on investment over the time period. Even factoring for goodwill, the economic profit has compensated...

Danaher ( NYSE: DHR ), which reported slowing topline growth in its Q4 2022 financial results earlier Tuesday, is impacting other life sciences tools and services providers. The biggest decliner among peers is Repligen ( NASDAQ: RGEN ), off ~4.3% . Others include Thermo Fi...